Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Mortality and immune-related adverse events after immune checkpoint inhibitor initiation for cancer among patients with pre-existing rheumatoid arthritis: a retrospective, comparative, cohort study.
Journal: The Lancet. Rheumatology
Published: October 16, 2023
Immunomodulator use, risk factors and management of flares, and mortality for patients with pre-existing rheumatoid arthritis after immune checkpoint inhibitors for cancer.
Journal: Seminars in arthritis and rheumatism
Published: September 23, 2023
Comparative safety and effectiveness of TNF inhibitors, IL6 inhibitors and methotrexate for the treatment of immune checkpoint inhibitor-associated arthritis.
Journal: Annals of the rheumatic diseases
Published: January 11, 2023
Predictors of Rheumatic Immune-Related Adverse Events and De Novo Inflammatory Arthritis After Immune Checkpoint Inhibitor Treatment for Cancer.
Journal: Arthritis & rheumatology (Hoboken, N.J.)
Published: May 08, 2021
Safety of Programmed Death-1 Pathway Inhibitors Among Patients With Non-Small-Cell Lung Cancer and Preexisting Autoimmune Disorders.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: May 11, 2018
Rheumatologic symptoms in oncologic patients on PD-1 inhibitors.
Journal: Seminars in arthritis and rheumatism
Published: July 20, 2017
Factors associated with fractures in HIV-infected persons: which factors matter?
Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA
Published: April 07, 2016
Rates of Serious Infections in HIV-Infected Patients Receiving Tumor Necrosis Factor Inhibitor Therapy for Concomitant Autoimmune Diseases.
Journal: Arthritis care & research
Published: March 17, 2016
Drug-associated polymyalgia rheumatica/giant cell arteritis occurring in two patients after treatment with ipilimumab, an antagonist of ctla-4.
Journal: Arthritis & rheumatology (Hoboken, N.J.)
Published: February 28, 2014
Comparative risk of fracture in men and women with HIV.
Journal: The Journal of clinical endocrinology and metabolism
Published: November 27, 2013
Bisphosphonates and risk of subtrochanteric, femoral shaft, and atypical femur fracture: a systematic review and meta-analysis.
Journal: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research
Published: September 21, 2012
Last Updated: 09/26/2026